Meeting Highlights From the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 April 2024
They are not yet approved for use in the UK, EU, or USA as of the time of publication
Medicinal plants for diabetes associated neurodegenerative diseases: a systematic review of preclinical studies
( A ) Intracellular accumulation of cAMP was measured by enzymatic immunoassay in lysates from caSMCs treated for 10 minutes with 100 nM each of GLP-1, forskolin, or PBS control, with or without 20 M sacubitril, a neutral endopeptidase inhibitor ( n = 3/treatment, each in triplicate)
Talk to your doctor about side effects first, so you know what to expect when you start a GLP-1 drug
The unpublished criteria include: 1